Editing 2C-T-7 (section)

====United States====
On September 20, 2002, 2C-T-7 was classified as a [[Controlled Substances Act#Schedule I controlled substances|Schedule I]] substance in the United States by an emergency ruling by the [[Drug Enforcement Administration|DEA]]. On March 18, 2004, the DEA published a Final Rule in the Federal Register permanently placing 2C-T-7 in Schedule I. (69 FR 12794)<ref name="s320"/><ref>{{cite web|url=http://www.usdoj.gov/ndic/pubs11/12207/12207p.pdf|title=2C-T-7 Fast Facts|author=U.S. [[United States Department of Justice|Department of Justice]]}}</ref><ref>{{Cite web |url=http://www.deadiversion.usdoj.gov/21cfr/cfr/1308/1308_11.htm |title=List of Schedule 1 drugs on the DEA Office of Diversion Control website |access-date=July 7, 2008 |archive-date=August 27, 2009 |archive-url=https://web.archive.org/web/20090827043725/http://www.deadiversion.usdoj.gov/21cfr/cfr/1308/1308_11.htm |url-status=dead }}</ref> 

As of April 2024, law enforcement have encountered 2C-T-7 in 16 states, with the highest number of encounters being in Florida. Purchases made over the internet are believed by the DEA to be the most common source by which users of the drug acquire it in the United States, and one laboratory manufacturing the drug was discovered by police in [[Las Vegas, Nevada]].<ref name="s320">{{cite web | title=2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (Street Names: 2C-T-7, Blue Mystic, T7, Beautiful, Tripstay, Tweety-Bird Mescaline) | url=https://www.deadiversion.usdoj.gov/drug_chem_info/2ct7.pdf | access-date=3 Sep 2024}}</ref>